Potent neutralizing monoclonal antibodies against Ebola virus infection

Ebola virus infections cause a deadly hemorrhagic disease for which no vaccines or therapeutics has received regulatory approval. Here we show isolation of three (Q206, Q314 and Q411) neutralizing monoclonal antibodies (mAbs) against the surface glycoprotein (GP) of Ebola virus identified in West Af...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qi, Gui, Miao, Niu, Xuefeng, He, Shihua, Wang, Ruoke, Feng, Yupeng, Kroeker, Andrea, Zuo, Yanan, Wang, Hua, Wang, Ying, Li, Jiade, Li, Chufang, Shi, Yi, Shi, Xuanling, Gao, George F., Xiang, Ye, Qiu, Xiangguo, Chen, Ling, Zhang, Linqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867612/
https://www.ncbi.nlm.nih.gov/pubmed/27181584
http://dx.doi.org/10.1038/srep25856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867612/
https://www.ncbi.nlm.nih.gov/pubmed/27181584
http://dx.doi.org/10.1038/srep25856

Ejemplares similares